Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus

EMBO Journal

Volumn 18, Issue 3, 1999, Pages 654-663

  Mann, David J ^a,b   Child, Emma S ^a   Swanton, Charles ^b   Laman, Heike ^b   Jones, Nic ^b  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cdk; Cyclin; Human herpesvirus 8; Kaposi's sarcoma; p27(Kip1)

Indexed keywords

ALANINE; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; PROTEIN P27; THREONINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BINDING SITES; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA PRIMERS; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION; HERPESVIRUS 8, HUMAN; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT PROTEINS; SPODOPTERA; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; MAMMALIA;

EID: 0033081065     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.3.654     Document Type: Article

References (53)

1. Bagchi, S., Raychaudhuri, P. and Nevins, J.R. (1990) Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell, 62, 659-669.
2. Bandara, L.R. and La Thangue, N.B. (1991) Adenovirus E1a prevents the retinoblastoma gene product from completing with a cellular transcription factor. Nature, 351, 494-497.
3. Bartek, J., Bartkova, J. and Lukas, J. (1996) The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol., 8, 805-814.
4. Boyle, W.J., van der Geer, P. and Hunter, T. (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin layer cellulose plates. Methods Enzymol., 201, 110-149.
5. Kip1 protein - prognostic implications in primary breast cancer. Nature Med., 3, 227-230.
6. Cesarman, E., Chang, Y.A., Moore, P.S., Said, J.W. and Knowles, D.M. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA-sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med., 332, 1186-1191.
7. Chang, Y., Moore, P.S., Talbot, S.J., Boshoff, C.H., Zarkowska, T., Godden-Kent, D., Paterson, H., Weiss, R.A. and Mittnacht, S. (1996) Cyclin encoded by KS herpesvirus. Nature, 382, 410.
8. Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M. and Nevins, J.R. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell, 65, 1053-1061.
9. Chen, Z.J., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D. and Maniatis, T. (1995) Signal-induced site specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev., 9, 1586-1597.
10. Clurman, B.E, Sheaff, R.J., Thress, K., Groudine, M. and Roberts, J.M. (1996) Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev., 10, 1979-1990.
11. Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
12. Diehl, J.A., Zindy, F. and Sherr, C.J. (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev., 11, 957-972.
13. Ewen, M.E. (1994) The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev., 13, 45-66.
14. Kip1-deficient mice. Cell, 85, 733-744.
15. Godden-Kent, D., Talbot, S.J., Boschoff, C., Chang, Y., Moore, P., Weiss, R.A and Mittnacht, S. (1997) The cyclin encoded by Kaposi's sarcoma-associated herpes virus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J. Virol., 71, 4193-4198.
16. Hall, M. and Peters, G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases and cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108.
17. Hara, E., Hall, M. and Peters, G. (1997) Cdk2-dependent phosphorylation of Id-2 modulates activity of e2a-related transcription factors. EMBO J., 16, 332-342.
18. 1/S transition. EMBO J., 13, 4302-4310.
19. 1 exit. Genes Dev., 10, 851-861.
20. Jung, J.U., Stager, M. and Desrosiers, R.C. (1994) Virus-encoded cyclin. Mol. Cell. Biol., 14, 7235-7244.
21. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. and Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene-product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev., 7, 331-342.
22. 1 phase arrest mediated by an inhibitor (p27) of cyclin-dependent kinase 4 activation. Cell, 79, 487-496.
23. Kip1 in human malignancies. Cancer Res., 55, 2266-2269.
24. Kip1. Cell, 85, 721-732.
25. 1 cyclin Cln2 induced by cdk-dependent phosphorylation. Science, 271, 1597-1601.
26. Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M. and Pagano, M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med., 3, 231-234.
27. Lukas, J., Parry, D., Aagard, L., Mann, D.J., Strauss, M., Peters, G. and Bartek, J. (1995) Retinoblastoma protein-dependent cell cycle inhibition by the tumour suppressor p16. Nature, 375, 503-506.
28. Kip1. Mol. Cell. Biol., 16, 6744-6751.
29. Kip1 by the viral E1a oncoprotein in TGF-β-treated cells, Nature, 380, 262-265.
30. 1 cell-cycle arrest. Curr. Biol., 6, 474-483.
31. Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, J.Y. (1994) D-type cyclin-dependent kinase-activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076.
32. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14, 2077-2086.
33. Muller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Asoroe, W., Huttner, W. and Eilers, M. (1997) Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
34. Kip1 display increased body-size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell. 85, 707-720.
35. Neufeld, E., Goren, H.J. and Boland, D. (1989) Thin-layer chromatography can resolve phosphotyrosine, phosphoserine and phosphothreonine in a protein hydrolysate. Anal. Biochem., 177, 138-143.
36. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature, 372, 570-573.
37. Pagano, M., Tam, S.W., Theodoras, A.M., Beerromero, P., Delsal, G., Chau, V., Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
38. Ink4/MTS1 tumor-suppressor gene-product. EMBO J., 14, 503-511.
39. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55, 1206-1210.
40. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
41. Kip1-chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55, 1211-1214.
42. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med., 3, 222-230.
43. Kip1 by cDNA antisense suppresses quiescence in fibroblasts. J. Biol. Chem., 271, 18337-18341.
44. Serrano, M., Hannon, G.J. and Beach, D. (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature, 366, 704-707.
45. Schulz, T.F., Chang, Y. and Moore, P.S. (1998) Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). In McCance, D.J. (ed.) Human Tumor Viruses. ASM Press, Washington DC, pp. 87-132.
46. Kip1. Genes Dev., 11, 1464-1478.
47. 1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
48. Swanton, C., Mann, D.J., Fleckenstein, B., Neipel, F., Peters, G. and Jones, N. (1997) Herpes viral cyclin/cdk6 complexes evade inhibition by cdk inhibitor proteins. Nature, 390, 184-187.
49. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
50. van den Heuvel, S. and Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science, 262, 2050-2054.
51. Kip1. EMBO J., 16, 5334-5344.
52. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
53. Won, K.A. and Reed, S.I. (1996) Activation of cyclin E/cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J., 15, 4182-4193.